1h
Jeffrey W. Sherman, MD, Joins DIMERx Board to Advance Next-Generation, Non-Addictive Pain Therapies
("DIMERx" or "the Company"), is a clinical-stage biopharmaceutical company dedicated to addressing the public-health crisis of drug abuse and dependence, with a portfolio of first-in-class, ...
DIMERx, Inc. ("DIMERx" or "the Company"), is a clinical-stage biopharmaceutical company dedicated to addressing the public-health crisis ...
Having exported dental supplies for more than 50 years, the ASX listed SDI is poised to be acquired by Chinese interests ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results